UROV

Urovant Sciences (UROV)

Urovant Sciences Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:UROV

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/04/14	01 : 02	Business Wire	Urovant Sciences to Present Interim Data from Phase 2a Study of Potential Novel Gene Therapy, URO-902, and New Analyses of Data from Phase 3 EMPOWUR Extension Trial of GEMTESA® (vibegron) 75 mg at 2022 American Urological Association Annual Meeting	NASDAQ:UROV	Urovant Sciences Ltd
2022/03/08	01 : 56	Business Wire	Urovant Sciences Announces Positive Topline Results of Phase 2a Trial of its Potential Novel Gene Therapy, URO-902	NASDAQ:UROV	Urovant Sciences Ltd
2021/12/21	02 : 11	Business Wire	Urovant Sciences Announces Publication in Advances in Therapy of Analyses of Patient-Perceived Meaningfulness of Improvement in Symptom Reduction for Overactive Bladder Patients Treated with GEMTESA® (vibegron) 75 mg	NASDAQ:UROV	Urovant Sciences Ltd
2021/11/08	22 : 00	Business Wire	Urovant Sciences Announces Publication in Blood Pressure Monitoring of Positive Ambulatory Blood Pressure Study Results for GEMTESA® (vibegron) 75 mg in Overactive Bladder Patients	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	19 : 14	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/04/01	01 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/31	01 : 13	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/30	04 : 13	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/30	04 : 09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/30	04 : 06	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/30	04 : 04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/29	21 : 44	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/29	21 : 36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:UROV	Urovant Sciences Ltd
2021/03/25	05 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/19	20 : 11	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/19	20 : 05	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/17	05 : 38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/13	07 : 43	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/13	06 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/13	06 : 05	Business Wire	Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results	NASDAQ:UROV	Urovant Sciences Ltd
2021/02/11	22 : 00	Business Wire	Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data & Safety Mon...	NASDAQ:UROV	Urovant Sciences Ltd